ifenprodil has been researched along with Neurodegenerative Diseases in 3 studies
ifenprodil: NMDA receptor antagonist
Neurodegenerative Diseases: Hereditary and sporadic conditions which are characterized by progressive nervous system dysfunction. These disorders are often associated with atrophy of the affected central or peripheral nervous system structures.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Trippier, PC | 1 |
Jansen Labby, K | 1 |
Hawker, DD | 1 |
Mataka, JJ | 1 |
Silverman, RB | 1 |
Rui, M | 1 |
Rossino, G | 1 |
Coniglio, S | 1 |
Monteleone, S | 1 |
Scuteri, A | 1 |
Malacrida, A | 1 |
Rossi, D | 1 |
Catenacci, L | 1 |
Sorrenti, M | 1 |
Paolillo, M | 1 |
Curti, D | 1 |
Venturini, L | 1 |
Schepmann, D | 1 |
Wünsch, B | 1 |
Liedl, KR | 1 |
Cavaletti, G | 1 |
Pace, V | 1 |
Urban, E | 1 |
Collina, S | 1 |
Mazumder, MK | 1 |
Borah, A | 1 |
1 review available for ifenprodil and Neurodegenerative Diseases
Article | Year |
---|---|
Target- and mechanism-based therapeutics for neurodegenerative diseases: strength in numbers.
Topics: Alzheimer Disease; Amyotrophic Lateral Sclerosis; Antioxidants; Calcium Channels; Drug Combinations; | 2013 |
2 other studies available for ifenprodil and Neurodegenerative Diseases
Article | Year |
---|---|
Identification of dual Sigma1 receptor modulators/acetylcholinesterase inhibitors with antioxidant and neurotrophic properties, as neuroprotective agents.
Topics: Acetylcholinesterase; Animals; Antioxidants; Blood-Brain Barrier; Cell Survival; Cholinesterase Inhi | 2018 |
Piroxicam inhibits NMDA receptor-mediated excitotoxicity through allosteric inhibition of the GluN2B subunit: an in silico study elucidating a novel mechanism of action of the drug.
Topics: Allosteric Site; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Calcium; Cells, Cultured; Human | 2014 |